People in the News

Premium

Cepheid said this week that Robert Kwiatkowski has joined the company as vice president of infectious disease research and development.

Kwiatkowski was most recently responsible for managing infectious disease test development in support of multiple automated platforms at Siemens Healthcare Diagnostics. He has also previously held positions at Gentra Systems, acquired by Qiagen in 2006; Third Wave Technologies, Becton Dickinson Molecular Diagnostics, and Digene Diagnostics. Kwiatkowski earned his PhD at John Hopkins University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.